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STUDY OBJECTIVES
In 2016, over 4,700 people died from opioid 
overdose in Pennsylvania. To reduce the risk of 
adverse outcomes from opioid use, ACEP 
clinical guidelines state that if opioids are 
prescribed at discharge, the prescription should 
be for the lowest practical dose for less than 
one week. Also, the prescriber should consider 
the patient’s risk factors for harmful use of 
these medications. In this quality improvement 
project initiated in August 2018, our emergency 
department (ED) implemented tapered opioid 
discharge prescription orders that ED providers 
can select with a single click in the electronic 
ordering system. While most emergency 
providers are cognizant of reducing overall 
number of opioids at discharge, the use of 
specific discharge opioid tapering protocols 
warrants further investigation.
METHODS
The hospital opioid stewardship committee met with the 
electronic medical record (EMR) team to develop new 
single-click orders for three ED opioid tapers: hydrocodone/
acetaminophen, oxycodone, and oxycodone/acetaminophen. 
Each option includes a prescription for seven 5-mg opioid 
pills with instructions for tapered use over three days:  
1 pill every 6 hours on day one, 1 pill every 12 hours on 
day two, and 1 pill once on day three. Education was then 
provided on these new prescription orders to residents, 
advanced practice clinicians, and attendings. For data 
gathering, the use of tapers within the EMR was tracked 
via a data analytics dashboard to determine the percentage 
of opioid discharge prescriptions utilizing the tapers on a 
monthly basis from August 2018 through March 2019. 
Average morphine milligram equivalent doses (MMED) for 
ED providers were tracked during this same time period, 
with a goal of maintaining average MMED per discharge 
prescription under 50 for all providers taken together. 
RESULTS
In July 2018, the month prior to implementing the 
opioid discharge tapered order option, 0% of 493 
total ED opioid prescriptions ordered at discharge 
utilized a taper, and the average MMED for ED 
providers was 34.67. After implementation in 
August 2018, average MMED per discharge 
prescription for the study time period remained 
under the goal of 50 MMED: 37.94. The 
percentage of opioid prescriptions that utilized the 
taper and average MMED for all ED providers by 
month were as follows: August 2018: 51/474 = 
10.76% (MMED = 38.5); September 2018: 
138/388 = 35.57% (MMED = 37.02); October 
2018: 129/387 = 33.33% (MMED = 37.84); 
November 2018: 121/372 = 32.53% (MMED = 
36.53); December 2018: 136/362 = 37.57% 
(MMED = 38.66); January 2019: 174/387 = 
44.96% (MMED = 41.86); February 2019: 
158/354 = 44.63% (MMED = 37.82); March 
2019: 146/353 = 41.36% (MMED = 35.30).
CONCLUSION
We conclude that implementing three different 
opioid 3-day/7-tablet taper options is feasible 
and increased the frequency of ED discharge 
opioid prescriptions that utilized a tapering 
dose. This change may improve patient safety 
by decreasing the risk of adverse outcomes 
related to opioid use, and it ensures discharge 
prescriptions are less than 50 MMED, as 
mandated by many commercial pharmacies  
for acute opioid prescribing. 
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